Siemens Healthineers‘ Varian announced today that it completed enrollment in treatment in its FAST-02 clinical trial.

Ongoing Phase 1 APOLLO study investigating MT-601 in patients with relapsed B cell lymphoma showed 66% of Non-Hodgkin Lymphoma (NHL) patients achieving objective response rates, with 50% demonstrating ...

The treatment that will help Catherine Illingworth's 5-year-old son is sitting in "the research valley of death," $6 million ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

Phase 2a trial designed to investigate the safety and preliminary analgesic efficacy of Trichomylin® softgel capsules ...

Cemdisiran monotherapy, dosed subcutaneously every three months, met the primary and key secondary endpoints, showing a 2.3-point placebo-adjusted improvement in Myasthenia Gravis Activities of Daily ...

Coya Therapeutics has announced the acceptance by the US FDA of IND application for COYA 302, paving the way for a Phase II ...

Baptist Health Hardin is the first in the world to begin in-human trials of 4D Mammography technology that could change how ...

Father-of-two battling rare mucosal melanoma which he said felt as though a rug had been pulled from under him ...

If you're looking for a collagen booster that's been hailed by skincare enthusiasts, check out this Elizabeth Grant collagen ...

Hemolytic Anemia - Global Clinical Trials Review, 2025" has been added to ResearchAndMarkets.com's offering. The report offers an in-depth look at the current landscape of clinical trials concerning ...

Phase 3 clinical trial results from Scripps Research and its collaborators supported FDA approval of ENCELTO, the first ...